Roles for CSN5 in control of p53/MDM2 activities

被引:71
|
作者
Zhang, Xiao-Chun [1 ]
Chen, Jian [1 ]
Su, Chun-Hui [1 ,2 ]
Yang, Heng-Yin [1 ]
Lee, Mong-Hong [1 ,2 ,3 ]
机构
[1] Univ Texas Houston, MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA
[2] Univ Texas Houston, Grad Sch Biomed Sci, Program Genes & Dev, Houston, TX USA
[3] Univ Texas Houston, Grad Sch Biomed Sci, Program Canc Biol, Houston, TX USA
关键词
MDM2; CSN5; ubiquitination; p53; curcumin;
D O I
10.1002/jcb.21504
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The 5th subunit of CON signalosome (CSN5, also known as Jab1 or COPS5) is implicated in regulating p53 activity and is overexpressed in various tumors. However, the precise roles of CSN5 in p53 network and tumorigenesis are not well characterized. Here we show that CSN5 is a critical regulator of both p53 and MDM2. We show that curcumin, an important inhibitor of CSN-associated kinases, can downregulate not only CSN5 but also MDM2, which results in p53 stabilization. Importantly, CSN5 interacts with p53. CSN5 expression leads to p53 degradation, facilitating MDM2-mediated p53 ubiquitination, and promoting p53 nuclear export. Additionally, CSN5 expression results in stabilization of MDM2 through reducing MDM2 self-ubiquitination and decelerating turnover rate of MDM2. Significantly, we further show that CSN5 antagonizes the transcriptional activity of p53. These results demonstrate that CSN5 is a pivotal regulator for both p53 and MDM2. Our studies may pave the way for targeting CSN5 for anti-cancer drug development.
引用
收藏
页码:1219 / 1230
页数:12
相关论文
共 50 条
  • [1] Mdm2: Keeping p53 under control
    Piette, J
    Neel, H
    Marechal, V
    [J]. ONCOGENE, 1997, 15 (09) : 1001 - 1010
  • [2] Mdm2: keeping p53 under control
    Jacques Piette
    Henry Neel
    Vincent Maréchal
    [J]. Oncogene, 1997, 15 : 1001 - 1010
  • [3] P53 Mdm2 Inhibitors
    Khoury, Kareem
    Doemling, Alex
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (30) : 4668 - 4678
  • [4] MDM2与p53
    金晶
    刘耕陶
    [J]. 癌症, 2001, (06) : 663 - 666
  • [5] MDM2 and BCL-2: to p53 or not to p53?
    Wang, Eunice S.
    [J]. BLOOD, 2023, 141 (11) : 1237 - 1238
  • [6] Binding of an inhibitor of the p53/MDM2 interaction to MDM2
    Duncan, SJ
    Cooper, MA
    Williams, DH
    [J]. CHEMICAL COMMUNICATIONS, 2003, (03) : 316 - 317
  • [7] p53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53
    Christine Wasylyk
    Roberto Salvi
    Manuela Argentini
    Christine Dureuil
    Isabelle Delumeau
    Joseph Abecassis
    Laurent Debussche
    Bohdan Wasylyk
    [J]. Oncogene, 1999, 18 : 1921 - 1934
  • [8] p53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53
    Wasylyk, C
    Salvi, R
    Argentini, M
    Dureuil, C
    Delumeau, I
    Abecassis, J
    Debussche, L
    Wasylyk, B
    [J]. ONCOGENE, 1999, 18 (11) : 1921 - 1934
  • [9] The roles and regulation of MDM2 and MDMX: it is not just about p53
    Klein, Alyssa M.
    de Queiroz, Rafaela Muniz
    Venkatesh, Divya
    Prives, Carol
    [J]. GENES & DEVELOPMENT, 2021, 35 (9-10) : 575 - 601
  • [10] The MDM2–p53 pathway: multiple roles in kidney development
    Samir S. El-Dahr
    Sylvia Hilliard
    Karam Aboudehen
    Zubaida Saifudeen
    [J]. Pediatric Nephrology, 2014, 29 : 621 - 627